Nureca Ltd Share Price – NSE  / BSE

E-Commerce/App based Aggregator, Small Cap

Net profit stood at Rs 3.73 crore in Q3 FY26, compared with a loss of Rs 2.80 crore in Q3 FY25. On a sequential basis, PAT rose 2.8% from Rs 3.63 crore in Q2 FY26.

Revenue from operations jumped 49.8% YoY to Rs 39.64 crore in Q3 FY26 from Rs 26.46 crore a year ago. Sequentially, revenue increased 5.0% from Rs 37.74 crore in Q2 FY26.

Profit before tax stood at Rs 4.66 crore in Q3 FY26, compared with a loss of Rs 3.25 crore in the year-ago quarter, and was broadly flat sequentially versus Rs 4.60 crore in Q2 FY26.

Total expenditure rose 19.4% YoY to Rs 36.39 crore during the quarter. Employee expenses increased 12.5% YoY to Rs 4.32 crore, while raw material costs surged 158.50% to Rs 10.34 crore from Rs 4.0 crore last year. Interest expense rose 55.56% YoY to Rs 0.28 crore from Rs 0.18 crore, while depreciation eased 7.4% YoY to Rs 0.50 crore.

The management stated that the financial performance was primarily driven by enhanced operational efficiencies, improved sourcing strategies, and strengthened manufacturing capabilities. Focused cost optimization, tighter supply chain controls, and productivity improvements enabled better margins, while scalable manufacturing capabilities supported sustainable growth and consistent execution.

Nureca continues to operate a digital-first, asset-light model, with over 90% of revenues generated through online channels. The company remains debt-free and maintains a healthy liquidity position.

Nureca is a digital healthcare company focused on home healthcare and wellness products.

Powered by Capital Market - Live News

Net profit of Nureca reported to Rs 3.73 crore in the quarter ended December 2025 as against net loss of Rs 2.80 crore during the previous quarter ended December 2024. Sales rose 49.81% to Rs 39.64 crore in the quarter ended December 2025 as against Rs 26.46 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Nureca will hold a meeting of the Board of Directors of the Company on 17 January 2026.

Powered by Capital Market - Live News

The board of Nureca at its meeting held on 28 November 2025 has approved buyback of 5.80 lakh equity shares of the company at a price of Rs 330 for an aggregate amount of Rs 19.14 crore.

Powered by Capital Market - Live News